
In this paper, a dynamic model of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) with periodic coefficients is proposed and studied. By using the continuation theorem of the coincidence degree theory, we obtain some sufficient conditions for the existence of positive periodic solutions of the model. The periodic model degenerates to an autonomous case, and our conditions can be degenerated to the basic reproductive number R0>1. Finally, we give some numerical simulations to illustrate our main theoretical results.
Citation: Tuersunjiang Keyoumu, Wanbiao Ma, Ke Guo. Existence of positive periodic solutions for a class of in-host MERS-CoV infection model with periodic coefficients[J]. AIMS Mathematics, 2022, 7(2): 3083-3096. doi: 10.3934/math.2022171
[1] | Shanshan Yu, Jiang Liu, Xiaojie Lin . Multiple positive periodic solutions of a Gause-type predator-prey model with Allee effect and functional responses. AIMS Mathematics, 2020, 5(6): 6135-6148. doi: 10.3934/math.2020394 |
[2] | Weijie Lu, Yonghui Xia . Periodic solution of a stage-structured predator-prey model with Crowley-Martin type functional response. AIMS Mathematics, 2022, 7(5): 8162-8175. doi: 10.3934/math.2022454 |
[3] | Zaitao Liang, Xuemeng Shan, Hui Wei . Multiplicity of positive periodic solutions of Rayleigh equations with singularities. AIMS Mathematics, 2021, 6(6): 6422-6438. doi: 10.3934/math.2021377 |
[4] | Kahkashan Mahreen, Qura Tul Ain, Gauhar Rahman, Bahaaeldin Abdalla, Kamal Shah, Thabet Abdeljawad . Approximate solution for the nonlinear fractional order mathematical model. AIMS Mathematics, 2022, 7(10): 19267-19286. doi: 10.3934/math.20221057 |
[5] | Axiu Shu, Xiaoliang Li, Bo Du, Tao Wang . Positive periodic stability for a neutral-type host-macroparasite equation. AIMS Mathematics, 2025, 10(3): 7449-7462. doi: 10.3934/math.2025342 |
[6] | Ping Zhu . Dynamics of the positive almost periodic solution to a class of recruitment delayed model on time scales. AIMS Mathematics, 2023, 8(3): 7292-7309. doi: 10.3934/math.2023367 |
[7] | Famei Zheng . Periodic wave solutions of a non-Newtonian filtration equation with an indefinite singularity. AIMS Mathematics, 2021, 6(2): 1209-1222. doi: 10.3934/math.2021074 |
[8] | Yan Yan . Multiplicity of positive periodic solutions for a discrete impulsive blood cell production model. AIMS Mathematics, 2023, 8(11): 26515-26531. doi: 10.3934/math.20231354 |
[9] | Zhongqian Wang, Dan Liu, Mingliang Song . Existence of three periodic solutions for a quasilinear periodic boundary value problem. AIMS Mathematics, 2020, 5(6): 6061-6072. doi: 10.3934/math.2020389 |
[10] | Shihong Zhu, Bo Du . Global attractive periodic solutions of neutral-type neural networks with delays in the leakage terms. AIMS Mathematics, 2023, 8(11): 26731-26744. doi: 10.3934/math.20231368 |
In this paper, a dynamic model of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) with periodic coefficients is proposed and studied. By using the continuation theorem of the coincidence degree theory, we obtain some sufficient conditions for the existence of positive periodic solutions of the model. The periodic model degenerates to an autonomous case, and our conditions can be degenerated to the basic reproductive number R0>1. Finally, we give some numerical simulations to illustrate our main theoretical results.
Middle East Respiratory Syndrome (MERS) is an acute respiratory disease caused by MERS-CoV, which was first reported in Saudi Arabia in 2012 [1]. Its main clinical features are fever, cough, dyspnea, shortness of breath, abdominal pain, nausea and diarrhea, etc [2,3]. Since the clinical symptoms may be non-specific, it is not always possible to identify patients with MERS-CoV in a timely manner. MERS-CoV probably originated in bats, and the intermediate host is dromedary camels [4]. It is a zoonotic virus, which means that it can be transmitted between animals and humans. Since its outbreak in 2012, cases have been reported in 27 countries (mostly in the Middle East), and more than 850 people are known to have died from the infection and related complications, with a case fatality rate of about 35% [5]. To date, no specific antiviral therapy has been approved for MERS-CoV infection, so treatment is primarily supportive and based on the patient's clinical condition; potential vaccines are in the early stages of development [4,5,6].
Usually, viruses can only invade a host by binding to specific receptors in the host body. Raj et al. [7] reported for the first time that dipeptidyl peptidase-4 (DPP4, also known as CD26) is a functional receptor for MERS-CoV. Studies have shown that DPP4 is mainly expressed in bronchial epithelial cells and lung tissue cells, and can also be expressed in MERS-CoV sensitive cells (such as Vero and Huh-7 cells) [7]. The binding of the MERS-CoV spike protein to DPP4 mediates the attachment of the virus to host cells and the virus-cell fusion, thus triggering infection [8]. Therefore, DPP4 plays an important role in MERS-CoV infection, which provides valuable input into the development of potential receptor-targeted vaccines and drugs. In recent decades, the dynamic model of viral infection has become an effective tool for people to understand the replication and clearance of various viruses (such as human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV)) in host [9,10,11].
Recently, in order to describe the interactions among uninfected cells, infected cells, MERS-CoV and DPP4, the authors in [12] proposed the following novel four dimensional autonomous ordinary differential equation model:
{˙T(t)=λ−βD(t)v(t)T(t)−dT(t),˙I(t)=βD(t)v(t)T(t)−d1I(t),˙v(t)=d1MI(t)−cv(t),˙D(t)=λ1−β1βD(t)v(t)T(t)−γD(t), | (1.1) |
where T(t), I(t), v(t) and D(t) represent the concentrations of uninfected cells, infected cells, free virus and DPP4 on the surface of uninfected cells at time t, respectively. λ, β, d, d1, M, c, λ1, β1 and γ are positive constants. λ is the rate at which uninfected cells are produced. β is the rate at which uninfected cells are infected by the free virus (i.e., infected cells are increased at a mount of βD(t)v(t)T(t), because uninfected cells are infected by the free virus). d and d1 represent the death rates of uninfected cells and infected cells, respectively. M represents the number of the free viruses released by lysis of each infected cell after death. c represents the death rate of the free viruses. λ1 represents the rate at which DPP4 is produced on the surface of uninfected cells. β1 represents the rate at which DPP4 is decreased (i.e., DPP4 is decreased at a mount of β1βD(t)v(t)T(t), because uninfected cells are infected by the free virus). γ represents the natural decay rate of DPP4. More detailed biological explanations can be found in literature [12].
The basic reproductive number of model (1.1) is given by R0=(λβMλ1)/(dcγ). By constructing the appropriate Lyapunov functions and combining with the Lyapunov-LaSalle invariance principle, the authors in [12] obtained that, if R0<1, then the infection-free equilibrium of model (1.1) is globally asymptotically stable; if R0>1 and some additional conditions hold, then the infected equilibrium is also globally asymptotically stable. The results suggest that MERS-CoV infection can also be controlled by reducing the expression rate (λ1) of DPP4. In addition, In [13], the authors applied the modeling idea of model (1.1) to the modeling of SARS-CoV-2 infection, and also took into consideration the effects of CTL immune response and pulsed administration therapy. It is shown that proper dosing intervals and drug dosages are both important in the eradication of viral infections.
It is well known that, periodic phenomena, such as the changes in the host's microenvironment with day and night, are common features in viral infection models. For example, some scholars have considered periodic drug therapy in viral infection models [14,15]. Therefore, it may be more reasonable to describe MERS-CoV infection using the model with periodic coefficients. Inspired by the research efforts above, in this paper, we will consider the following non-autonomous MERS-CoV dynamic model with periodic coefficients:
{˙T(t)=λ(t)−β(t)D(t)v(t)T(t)−d(t)T(t),˙I(t)=β(t)D(t)v(t)T(t)−d1(t)I(t),˙v(t)=d1(t)M(t)I(t)−c(t)v(t),˙D(t)=λ1(t)−β1(t)β(t)D(t)v(t)T(t)−γ(t)D(t). | (1.2) |
In model (1.2), λ(t), β(t), d(t), d1(t), M(t), c(t), λ1(t), β1(t) and γ(t) are all assumed to be positive, continuous and periodic functions with positive upper and lower bounds and share the same period ω>0. All the parameters in model (1.2) have exactly the same biological significance with those in model (1.1).
There are abundant research results on the existence of periodic solutions of nonlinear ordinary differential equations. The main research methods mainly include fixed point theorems, Lyapunov's second method, coincidence degree theory and so on. Especially, in recent years, the continuation theorem of the coincidence degree theory [16] has been successfully applied to the study of the existence of periodic solutions of some classic biological models, such as the models in population biology [17,18,19,20], the models in epidemiology [21,22], and the models in microbiology [23,24], etc.
The main purpose of this paper is to establish some sufficient conditions for the existence of positive ω-periodic solutions of model (1.2) by using the continuation theorem in the coincidence degree theory.
The remaining part of this paper is organized as follows. In Section 2, some sufficient conditions are given for the existence of positive ω-periodic solutions of model (1.2). In Section 3, the conclusions and some numerical simulations are presented.
For convenience, let us first introduce the following well-known the continuation theorem in the coincidence degree theory [16].
Let X and Z be two Banach spaces, L:DomL⊂X→Z be a linear mapping, N:X→Z be a continuous mapping. The mapping L will be called a Fredholm mapping of index zero, if dimKerL=codimImL<+∞ and ImL is closed in Z. If L is a Fredholm mapping of index zero and there exist continuous projectors idempotent operator P:X→X and Q:Z→Z such that ImP=KerL, ImL=KerQ=Im(I−Q), it follows that L∣DomL∩KerP:(I−P)X→ImL is invertible. We denote the generalized inverse of that map by KP. Let Ω be an open bounded subset of X. The mapping N will be called L-compact on ¯Ω, if QN(¯Ω) is bounded and KP(I−Q)N:¯Ω→ImL is compact. Since ImQ is isomorphic to KerL, there exists an isomorphism J:ImQ→KerL.
Lemma 2.1. (Continuationtheorem) [16] Assume that Ω⊂X be an open bounded set. Let L be a Fredholm mapping of index zero and let N:¯Ω→Z be L-compact on ¯Ω. Assume
(ⅰ) for each μ∈(0,1), x∈∂Ω∩DomL, Lx≠μNx;
(ⅱ) for each x∈∂Ω∩KerL, QNx≠0;
(ⅲ) deg{JQN,Ω∩KerL,0}≠0.
Then the operator equation Lx=Nx has at least one solution in DomL∩¯Ω.
For the sake of convenience in the presentation, for any continuous ω-periodic function f(t) defined on R, we define the following notations,
ˆf=1ω∫ω0f(s)ds,fl=mint∈[0,ω]f(t),fu=maxt∈[0,ω]f(t). |
Furthermore, let us define the following parameters,
R∗=(λd)l(λ1γ)l(βc)lMl,E∗=(βc)lMl,M1=ln(ˆλˆd+2ˆλω),M2=ln(ˆλ^d1)+2^d1ω,M3=ln(^(d1M)ˆc)+M2+2ˆcω,M4=ln(^λ1ˆγ+2^λ1ω). |
The following two conditions will be used:
(H1) 2(ˆd+ˆβexp{M3+M4})ω<1;
(H2) 2(ˆγ+^(β1β)exp{M1+M3})ω<1.
Let us give the main result of this paper.
Theorem 2.1. If R∗>1 and conditions (H1) and (H2) hold, then model (1.2) has at least one positive ω-periodic solution.
Proof. By using the following variable transformation,
T(t)=exp{x1(t)},I(t)=exp{x2(t)},v(t)=exp{x3(t)},D(t)=exp{x4(t)}, |
model (1.2) can be rewrite as
{˙x1(t)=λ(t)exp{x1(t)}−β(t)exp{x3(t)+x4(t)}−d(t),˙x2(t)=β(t)exp{x1(t)+x3(t)+x4(t)}exp{x2(t)}−d1(t),˙x3(t)=d1(t)M(t)exp{x2(t)}exp{x3(t)}−c(t),˙x4(t)=λ1(t)exp{x4(t)}−β1(t)β(t)exp{x1(t)+x3(t)}−γ(t). | (2.1) |
Obviously, if model (2.1) exists a ω-periodic solution, then model (1.2) exists a positive ω-periodic solution. Therefore, we only need to study the existence of ω-periodic solutions of model (2.1).
We define
X=Z={x=(x1(t),x2(t),x3(t),x4(t))T∈C(R,R4)|x(t)=x(t+ω)} |
with the norm
||x||=maxt∈[0,ω]|x1(t)|+maxt∈[0,ω]|x2(t)|+maxt∈[0,ω]|x3(t)|+maxt∈[0,ω]|x4(t)|. |
It is easily to verify that X and Z are Banach spaces. Define
Nx=[λ(t)exp{x1(t)}−β(t)exp{x3(t)+x4(t)}−d(t)β(t)exp{x1(t)+x3(t)+x4(t)}exp{x2(t)}−d1(t)d1(t)M(t)exp{x2(t)}exp{x3(t)}−c(t)λ1(t)exp{x4(t)}−β1(t)β(t)exp{x1(t)+x3(t)}−γ(t)]:=[N1(t)N2(t)N3(t)N4(t)](x∈X), | (2.2) |
Lx=˙x(x∈DomL),Px=1ω∫ω0x(t)dt(x∈X),Qx=1ω∫ω0x(t)dt(x∈Z), |
where DomL={x∈X,˙x∈X}. Then it follows that
KerL={x∈X|x∈R4},ImL={x∈Z|∫ω0x(t)dt=0}. |
Obviously, ImL is closed in Z and dimKerL=codimImL=4. Thus, L is a Fredholm mapping of index zero. Furthermore, the generalized (to L) inverse KP:ImL→DomL∩KerP exists and is given by
KPx=∫t0x(s)ds−1ω∫ω0∫t0x(s)dsdt. |
Thus
QNx=[1ω∫ω0N1(s)ds,1ω∫ω0N2(s)ds,1ω∫ω0N3(s)ds,1ω∫ω0N4(s)ds]T, |
and
KP(I−Q)Nx=[∫ω0N1(s)ds−1ω∫ω0∫t0N1(s)dsdt−(tω−12)∫ω0N1(s)ds∫ω0N2(s)ds−1ω∫ω0∫t0N2(s)dsdt−(tω−12)∫ω0N2(s)ds∫ω0N3(s)ds−1ω∫ω0∫t0N3(s)dsdt−(tω−12)∫ω0N3(s)ds∫ω0N4(s)ds−1ω∫ω0∫t0N4(s)dsdt−(tω−12)∫ω0N4(s)ds]. |
It is not difficult to show that QN and KP(I−Q)N are continuous. By using Arzela-Ascoli theorem, we can also show that QN(¯Ω) and KP(I−Q)N(¯Ω) are compact for any open bounded set Ω in X. Furthermore, it is obvious that QN(¯Ω) is bounded. Thus N is L-compact on ¯Ω for any open bounded set Ω in X.
Corresponding to the operator equation Lx=μNx, μ∈(0,1), we have
{˙x1(t)=μ[λ(t)exp{x1(t)}−β(t)exp{x3(t)+x4(t)}−d(t)],˙x2(t)=μ[β(t)exp{x1(t)+x3(t)+x4(t)}exp{x2(t)}−d1(t)],˙x3(t)=μ[d1(t)M(t)exp{x2(t)}exp{x3(t)}−c(t)],˙x4(t)=μ[λ1(t)exp{x4(t)}−β1(t)β(t)exp{x1(t)+x3(t)}−γ(t)]. | (2.3) |
Assume that x=(x1(t),x2(t),x3(t),x4(t))T∈X is an arbitrary solution of model (2.3) for the parameter μ∈(0,1). It is obvious that, (T(t),I(t),v(t),D(t))T:=(exp{x1(t)},exp{x2(t)},exp{x3(t)}, exp{x4(t)})T is a solution of the following model,
{˙T(t)=μ[λ(t)−β(t)D(t)v(t)T(t)−d(t)T(t)],˙I(t)=μ[β(t)D(t)v(t)T(t)−d1(t)I(t)],˙v(t)=μ[d1(t)M(t)I(t)−c(t)v(t)],˙D(t)=μ[λ1(t)−β1(t)β(t)D(t)v(t)T(t)−γ(t)D(t)]. | (2.4) |
Integrating the left and right sides of (2.3) and (2.4) over the interval [0,ω], we have
{∫ω0[λ(t)exp{x1(t)}−β(t)exp{x3(t)+x4(t)}−d(t)]dt=0,∫ω0[β(t)exp{x1(t)+x3(t)+x4(t)}exp{x2(t)}−d1(t)]dt=0,∫ω0[d1(t)M(t)exp{x2(t)}exp{x3(t)}−c(t)]dt=0,∫ω0[λ1(t)exp{x4(t)}−β1(t)β(t)exp{x1(t)+x3(t)}−γ(t)]dt=0, | (2.5) |
and
{∫ω0[λ(t)−β(t)D(t)v(t)T(t)−d(t)T(t)]dt=0,∫ω0[β(t)D(t)v(t)T(t)−d1(t)I(t)]dt=0,∫ω0[d1(t)M(t)I(t)−c(t)v(t)]dt=0,∫ω0[λ1(t)−β1(t)β(t)D(t)v(t)T(t)−γ(t)D(t)]dt=0. | (2.6) |
From (2.5) and the second and third equations of (2.3), we have
∫ω0|˙x2(t)|dt≤μ[∫ω0β(t)exp{x1(t)+x3(t)+x4(t)}exp{x2(t)}dt+∫ω0d1(t)dt]<2^d1ω,∫ω0|˙x3(t)|dt≤μ[∫ω0d1(t)M(t)exp{x2(t)}exp{x3(t)}dt+∫ω0c(t)dt]<2ˆcω. | (2.7) |
In addition, from (2.6) and the first and fourth equations of (2.4), we have
∫ω0|˙T(t)|dt≤μ[∫ω0λ(t)dt+∫ω0(β(t)D(t)v(t)T(t)+d(t)T(t))dt]<2ˆλω,∫ω0|˙D(t)|dt≤μ[∫ω0λ1(t)dt+∫ω0(β1(t)β(t)D(t)v(t)T(t)+γ(t)D(t))dt]<2^λ1ω. | (2.8) |
For x∈X, there exist ξi,ηi∈[0,ω] (i=1,2,3,4) such that
xi(ξi)=mint∈[0,ω]xi(t),xi(ηi)=maxt∈[0,ω]xi(t)(i=1,2,3,4). |
Obviously, it has ˙xi(ξi)=0, ˙xi(ηi)=0 (i=1,2,3,4).
From the first equation of (2.5), we have
∫ω0λ(t)exp{x1(ξ1)}dt≥ˆdω, |
which, together with (2.4) and (2.8), imply that
T(t)≤T(ξ1)+∫ω0|˙T(t)|dt=exp{x1(ξ1)}+∫ω0|˙T(t)|dt≤ˆλˆd+2ˆλω. |
Hence, we have
x1(t)≤ln(ˆλˆd+2ˆλω)=M1. | (2.9) |
Similarly, we can obtain
x4(t)≤ln(^λ1ˆγ+2^λ1ω)=M4. | (2.10) |
Adding the first and the second equations of (2.6), we have
ˆλω=∫ω0[d(t)T(t)+d1(t)I(t)]dt=∫ω0[d(t)exp{x1(t)}+d1(t)exp{x2(t)}]dt, |
which implies that
ˆλω≥∫ω0[d1(t)exp{x2(ξ2)}]dt=exp{x2(ξ2)}^d1ω. | (2.11) |
From (2.7) and (2.11), we have
x2(t)≤x2(ξ2)+∫ω0|˙x2(t)|dt≤ln(ˆλ^d1)+2^d1ω=M2. | (2.12) |
From the third equation of (2.5), we have
ˆcω≤∫ω0d1(t)M(t)exp{M2}exp{x3(ξ3)}dt=^(d1M)exp{M2}exp{x3(ξ3)}ω, |
which implies that
x3(ξ3)≤ln(^(d1M)ˆc)+M2. |
Hence, from (2.7), we have
x3(t)≤x3(ξ3)+∫ω0|˙x3(t)|dt≤ln(^(d1M)ˆc)+M2+2ˆcω=M3. | (2.13) |
In the following, let us further give lower bounds of xi(t) (i=1,2,3,4). It should be mentioned here that, due to the particularity of mode (1.2), we will use a method different from that in the literature to obtain the estimations of the lower bounds.
From the first equation of (2.5), (2.10) and (2.13), we have
∫ω0[λ(t)exp{x1(η1)}−β(t)exp{M3+M4}−d(t)]dt≤0, |
which implies that
exp{x1(η1)}≥ˆλˆd+ˆβexp{M3+M4}. |
Further, from condition (H1) and (2.8), we have
T(t)≥T(η1)−∫ω0|˙T(t)|dt=exp{x1(η1)}−∫ω0|˙T(t)|dt≥ˆλˆd+ˆβexp{M3+M4}−2ˆλω>0, |
which implies that
x1(t)≥ln(ˆλˆd+ˆβexp{M3+M4}−2ˆλω):=L1. | (2.14) |
Similarly, using condition (H2), we can obtain
x4(t)≥ln(^λ1ˆγ+^(β1β)exp{M1+M3}−2^λ1ω):=L4. |
In the following, to obtain lower bounds for x2(t) and x3(t), we need the following two important claims.
Claim (ⅰ).
mint∈[0,ω]{exp{x1(t)+x4(t)}}≤1E∗. |
If Claim (ⅰ) is not true, then it has mint∈[0,ω]{exp{x1(t)+x4(t)}}>1E∗. We define
G(t)=Mlexp{x2(t)}+exp{x3(t)}. |
Obviously, G(0)=G(ω). Calculating the derivative of G(t) along the solution of model (2.3) yields
˙G(t)=Mlexp{x2(t)}˙x2(t)+exp{x3(t)}˙x3(t)=μ[Mlβ(t)exp{x1(t)+x3(t)+x4(t)}−c(t)exp{x3(t)}+d1(t)(M(t)−Ml)exp{x2(t)}]≥μMlβ(t)[exp{x1(t)+x4(t)}−c(t)Mlβ(t)]exp{x3(t)}≥μMlβ(t)[mint∈[0,ω]{exp{x1(t)+x4(t)}}−1E∗]exp{x3(t)}>0, |
which implies that G(ω)>G(0). This is a contradiction. Thus, Claim (ⅰ) is true.
If R∗>1, then there exists a positive constant δ∗>0 such that
(λd+βexp{M4}δ∗)l(λ1γ+ββ1exp{M1}δ∗)l>1E∗. | (2.15) |
Claim (ⅱ). If R∗>1, then
maxt∈[0,ω]{x3(t)}≥ln(δ∗). |
If Claim (ⅱ) is not true, then it has maxt∈[0,ω]{x3(t)}<ln(δ∗), i.e. maxt∈[0,ω]{exp{x3(t)}}<δ∗. From ˙x1(ξ1)=0 and (2.10), we have
exp{x1(ξ1)}=λ(ξ1)d(ξ1)+β(ξ1)exp{x3(ξ1)+x4(ξ1)}≥λ(ξ1)d(ξ1)+β(ξ1)δ∗exp{M4}≥(λd+βδ∗exp{M4})l. | (2.16) |
Similarly, from ˙x4(ξ4)=0 and (2.9), we can obtain
exp{x4(ξ4)}≥(λ1γ+ββ1exp{M1}δ∗)l. | (2.17) |
From (2.15)–(2.17), we have
exp{x1(ξ1)+x4(ξ4)}≥(λd+βexp{M4}δ∗)l(λ1γ+ββ1exp{M1}δ∗)l>1E∗, |
which implies that
mint∈[0,ω]{exp{x1(t)+x4(t)}}≥(mint∈[0,ω]{exp{x1(t)}})(mint∈[0,ω]{exp{x4(t)}})=exp{x1(ξ1)+x4(ξ4)}>1E∗. |
This contradicts with Claim (ⅰ). Thus Claim (ⅱ) is proved.
From Claim (ⅱ) and (2.7), we have
x3(t)≥x3(η3)−∫ω0|˙x3(t)|dt≥ln(δ∗)−2ˆcω:=L3. |
From the second equation of (2.5), we have
^d1ω≥∫ω0β(t)exp{L1+L3+L4}exp{x2(η2)}dt, |
which implies that
x2(η2)≥ln(ˆβ^d1)+L1+L3+L4. |
Further, from (2.7), we have
x2(t)≥x2(η2)−∫ω0|˙x2(t)|dt≥ln(ˆβ^d1)+L1+L3+L4−2^d1ω:=L2. |
Obviously, Mi, Li (i=1,2,3,4) are independent of μ.
Let (x1,x2,x3,x4)T∈R4 satisfy the following algebraic equations
{ˆλexp{x1}−ˆβexp{x3+x4}−ˆd=0,ˆβexp{x1+x3+x4}exp{x2}−^d1=0,^(d1M)exp{x2}exp{x3}−ˆc=0,^λ1exp{x4}−^(β1β)exp{x1+x3}−ˆγ=0. | (2.18) |
It is not difficult to show that if R∗>1, then it has
¯R0:=ˆλˆβ^(d1M)^λ1ˆd^d1ˆcˆγ>1. |
Completely similar to the results of the existence of positive equilibrium in [12], we can easily obtain that if ¯R0>1, then (2.18) has a unique solution (x∗1,x∗2,x∗3,x∗4)T∈R4 which satisfies
exp{x∗1}=ˆλˆd−ˆc^d1^(d1M)ˆdexp{x∗3}=^(d1M)(ˆλ^(ββ1)−^λ1ˆβ)+√Δ2^(β1β)^(d1M)ˆd>0,exp{x∗2}=ˆc^(d1M)exp{x∗3}>0,exp{x∗4}=ˆc^d1^(d1M)ˆβexp{x∗1}>0,exp{x∗3}=^(d1M)(^λ1ˆβ+ˆλ^(β1β))−√Δ2^(β1β)ˆc^d1=2^(d1M)ˆdˆγ(¯R0−1)^(d1M)(^λ1ˆβ+ˆλ^(β1β))+√Δ>0, | (2.19) |
where
Δ=(^(d1M))2(^λ1ˆβ−ˆλ^(β1β))2+4^(d1M)^(β1β)ˆcˆdˆγ^d1>0. |
We define the set Ω={x∈X|||x||<U}, where
U=1+4∑i=1(max{|Mi|,|Li|}+|x∗i|). |
It is clear that Ω satisfies the condition(ⅰ) in Lemma 2.1. When ˜x=(x1,x2,x3,x4)T∈∂Ω∩KerL=∂Ω∩R4, then ˜x is a constant vector in R4 with |x1|+|x2|+|x3|+|x4|=U>|x∗1|+|x∗2|+|x∗3|+|x∗4|. Then, we have
QN[x1x2x3x4]=[ˆλexp{x1}−ˆβexp{x3+x4}−ˆdˆβexp{x1+x3+x4}exp{x2}−^d1^(d1M)exp{x2}exp{x3}−ˆc^λ1exp{x4}−^(β1β)exp{x1+x3}−ˆγ]≠[0000]. |
This shows that Ω satisfies the condition (ⅱ) in Lemma 2.1. Next, let us prove that the condition (ⅲ) in Lemma 2.1 is also satisfied. Let
e1=exp{x∗1}>0,e2=exp{x∗2}>0,e3=exp{x∗3}>0,e4=exp{x∗4}>0. |
Note that J=I since ImQ=KerL. Furthermore, by simple calculation, we have
deg{JQN,∂Ω∩KerL,(0,0,0,0)T}=deg{QN,∂Ω∩KerL,(0,0,0,0)T}=sign|−ˆλe10−ˆβe3e4−ˆβe3e4ˆβe1e3e4e2−ˆβe1e3e4e2ˆβe1e3e4e2ˆβe1e3e4e20^(d1M)e2e3−^(d1M)e2e30−^(β1β)e1e30−^(β1β)e1e3−^λ1e4|=sign[ˆβ^(d1M)e1e3e4((^λ1ˆβ+ˆλ^(β1β))−2ˆβ^(β1β)e1e3e4)]=sign[^λ1ˆβ+ˆλ^(β1β)2ˆβ^(β1β)e1e4−e3]. |
In addition, from (2.19), we can obtain
e1e4=ˆc^d1^(d1M)ˆβ,e3<^(d1M)(^λ1ˆβ+ˆλ^(β1β))2^(β1β)ˆc^d1=^λ1ˆβ+ˆλ^(β1β)2ˆβ^(β1β)e1e4:=~e3. | (2.20) |
Then, from (2.20), we have
deg{JQN,∂Ω∩KerL,(0,0,0,0)T}=sign[~e3−e3]=1≠0. |
Thus, the condition (ⅲ) in Lemma 2.1 is also satisfied. Therefore, from Lemma 2.1, we have that model (2.1) has at least one ω-periodic solution. Thus, model (1.2) has at least one positive ω-periodic solution.
Remark 2.1. It should be mentioned here that, if all the periodic coefficients in model (1.2) are taken as positive constants, then model (1.2) degenerates to model (1.1), and R∗ naturally becomes R0. Furthermore, note that, for model (1.1), the conditions (H1) and (H2) are naturally satisfied, and the condition R0>1 implies the existence of unique positive equilibrium. These show that, for the existence of positive periodic solutions of model (1.2), the conditions (H1) and (H2) in Theorem 2.1 may be reasonable.
In this paper, the existence of positive periodic solutions of a class of MERS-CoV infection dynamic model (1.2) with periodic coefficients is studied by using the continuation theorem of the coincidence degree theory. By estimating technically the upper and lower bounds of the prior solutions of the corresponding operator equation (Lx=μNx), we obtain the sufficient conditions for the existence of positive periodic solutions of model (1.2). If model (1.2) degenerates to an autonomous one, our sufficient conditions become the basic reproductive number R0>1.
In model (1.2) ((1.1)), the interaction between DPP4 and virus infection is considered. From the expression of the basic reproductive number R∗ (R0), it can be seen that adjusting the growth rate λ1(t) (λ1) of DPP4 may be one of control strategies for the controlling of virus infection as well as drug therapy. In addition, for model (1.2) ((1.1)) it may be interesting to introduce the time lags in the process of virus infection and immune response in the bodies, which will be discussed in another papers.
At the end of the paper, we present numerical simulations to illustrate our theoretical results. The following parameters are taken
λ(t)=0.2+0.1sin(10t),β(t)=0.001+0.0005sin(10t),d(t)=0.02+0.01cos(10t),d1(t)=0.1+0.05cos(10t),M(t)=3,c(t)=0.06+0.05sin(10t),λ1(t)=0.5+0.3sin(10t),β1(t)=0.1+0.05sin(10t),γ(t)=0.01+0.005cos(10t). | (3.1) |
Obviously, ω=π/5. The calculation gives R∗≈3.43>1, M1≈2.327, M2≈0.819, M3≈2.504, M4≈3.925,
2(ˆd+ˆβexp{M3+M4})ω≈0.803<1,2(ˆγ+^(β1β)exp{M1+M3})ω≈0.0303<1. |
Thus, conditions (H1) and (H2) hold. From Theorem 2.1, model (1.2) has at least one positive (π/5)-periodic solution (see Figure 1).
This paper is supported by National Natural Science Foundation of China (No.11971055) and Beijing Natural Science Foundation (No.1202019).
The authors declare there is no conflict of interest in this paper.
[1] |
A. M. Zaki, S. van Boheemen, T. M. Bestebroer, A. D. M. E. Osterhauset, R. A. M. Fouchier, Isolation of a novel coronavirus from a man with pneumonia in saudi arabia, New Engl. J. Med., 367 (2012), 1814–1820. doi: 10.1056/NEJMoa1211721. doi: 10.1056/NEJMoa1211721
![]() |
[2] |
A. Assiri, J. A. Al-Tawfiq, A. A. Al-Rabeeah, F. A. Al-Rabiah, S. Al-Hajjar, A. Al-Barrak, et al., Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study, Lancet Infect. Dis., 13 (2013), 752–761. doi: 10.1016/S1473-3099(13)70204-4. doi: 10.1016/S1473-3099(13)70204-4
![]() |
[3] |
M. S. Nassar, M. A. Bakhrebah, S. A. Meo, M. S. Alsuabeyl, W. A. Zaheret, Middle east respiratory syndrome coronavirus (MERS-CoV) infection: Epidemiology, pathogenesis and clinical characteristics, Eur. Rev. Med. Pharmaco., 22 (2018), 4956–4961. doi: 10.26355/eurrev_201808_15635. doi: 10.26355/eurrev_201808_15635
![]() |
[4] |
A. M. Alnuqaydan, A. G. Almutary, A. Sukamaran, B. T. W. Yang, X. T. Lee, W. X. Lim, et al., Middle east respiratory syndrome (MERS) virus-pathophysiological axis and the current treatment strategies, AAPS PharmSciTech, 22 (2021), 173. doi: 10.1208/s12249-021-02062-2. doi: 10.1208/s12249-021-02062-2
![]() |
[5] | World Health Organization, Middle east respiratory syndrome coronavirus (MERS-CoV), 2019. |
[6] |
Y. M. Arabi, H. H. Balkhy, F. G. Hayden, A. Bouchama, T. Luke, J. K. Baillie, et al., Middle east respiratory syndrome, New Engl. J. Med., 376 (2017), 584–594. doi: 10.1056/NEJMsr1408795. doi: 10.1056/NEJMsr1408795
![]() |
[7] |
V. S. Raj, H. Mou, S. L. Smits, D. H. W. Dekkers, M. A. Müller, R. Dijkman, et al., Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC, Nature, 495 (2013), 251–254. doi: 10.1038/nature12005. doi: 10.1038/nature12005
![]() |
[8] |
G. Lu, Y. Hu, Q. Wang, J. Qi, F. Gao, Y. Li, et al., Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26, Nature, 500 (2013), 227–231. doi: 10.1038/nature12328. doi: 10.1038/nature12328
![]() |
[9] |
M. A. Nowak, C. R. M. Bangham, Population dynamics of immune responses to persistent virus, Science, 272 (1997), 74–79. doi: 10.1126/science.272.5258.74. doi: 10.1126/science.272.5258.74
![]() |
[10] |
A. U. Neumann, N. P. Lam, H. Dahari, D. R. Gretch, T. E. Wiley, T. J. Layden, et al., Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy, Science, 282 (1998), 103–107. doi: 10.1126/science.282.5386.103. doi: 10.1126/science.282.5386.103
![]() |
[11] |
A. S. Perelson, P. W. Nelson, Mathematical analysis of HIV-1 dynamics in vivo, SIAM Rev., 41 (1999), 3–44. doi: 10.1137/S0036144598335107. doi: 10.1137/S0036144598335107
![]() |
[12] |
S. Tang, W. Ma, P. Bai, A novel dynamic model describing the spread of the MERS-CoV and the expression of dipeptidyl peptidase 4, Comput. Math. Method. M., 2017 (2017), 5285810. doi: 10.1155/2017/5285810. doi: 10.1155/2017/5285810
![]() |
[13] |
A. N. Chatterjee, F. Al Basir, A model for SARS-CoV-2 infection with treatment, Comput. Math. Method. M., 2020 (2020), 1352982. doi: 10.1155/2020/1352982. doi: 10.1155/2020/1352982
![]() |
[14] |
P. D. Leenheer, Within-host virus models with periodic antiviral therapy, Bull. Math. Biol., 71 (2009), 189–210. doi: 10.1007/s11538-008-9359-5. doi: 10.1007/s11538-008-9359-5
![]() |
[15] |
Y. Yang, Y. Xiao, Threshold dynamics for an HIV model in periodic environments, J. Math. Anal. Appl., 361 (2010), 59–68. doi: 10.1016/j.jmaa.2009.09.012. doi: 10.1016/j.jmaa.2009.09.012
![]() |
[16] | R. E. Gaines, J. L. Mawhin, Coincidence degree and nonlinear differential equations, Berlin: Springer-Verlag, 1977. doi: 10.1007/BFb0089537. |
[17] | Y. Li, Periodic solutions of a periodic delay predator-prey system, P. Am. Math. Soc., 127 (1999), 1331–1335. doi: S0002-9939(99)05210-7. |
[18] | Y. Li, Y. Kuang, Periodic solutions of periodic delay Lotka-Volterra equations and systems, J. Math. Anal. Appl., 255 (2001), 260–280. doi: 10.1006jmaa.2000.7248. |
[19] |
M. Fan, K. Wang, Periodicity in a delayed ratio-dependent predator-prey system, J. Math. Anal. Appl., 262 (2001), 179–190. doi: 10.1006/jmaa.2001.7555. doi: 10.1006/jmaa.2001.7555
![]() |
[20] |
D. Bai, J. Yu, M. Fan, Y. Kang, Dynamics for a non-autonomous predator-prey system with generalist predator, J. Math. Anal. Appl., 485 (2020), 123820. doi: 10.1016/j.jmaa.2019.123820. doi: 10.1016/j.jmaa.2019.123820
![]() |
[21] |
Z. Bai, Y. Zhou, T. Zhang, Existence of multiple periodic solutions for an SIR model with seasonality, Nonlinear Anal., 74 (2011), 3548–3555. doi: 10.1016/j.na.2011.03.008. doi: 10.1016/j.na.2011.03.008
![]() |
[22] |
T. Zhang, J. Liu, Z. Teng, Existence of positive periodic solutions of an SEIR model with periodic coefficients, Appl. Math. CZECH, 57 (2012), 601–616. doi: 10.1007/s10492-012-0036-5. doi: 10.1007/s10492-012-0036-5
![]() |
[23] |
H. Zhao, L. Sun, Periodic oscillatory and global attractivity for chemostat model involving distributed delays, Nonlinear Anal.-Real, 7 (2006), 385–394. doi: 10.1016/j.nonrwa.2005.03.007. doi: 10.1016/j.nonrwa.2005.03.007
![]() |
[24] |
P. Amster, G. Robledo, D. Sepúlveda, Existence of ω-periodic solutions for a delayed chemostat with periodic inputs, Nonlinear Anal.-Real, 55 (2020), 103134. doi: 10.1016/j.nonrwa.2020.103134. doi: 10.1016/j.nonrwa.2020.103134
![]() |
1. | Tuersunjiang Keyoumu, Wanbiao Ma, Ke Guo, Global Stability of a MERS-CoV Infection Model with CTL Immune Response and Intracellular Delay, 2023, 11, 2227-7390, 1066, 10.3390/math11041066 | |
2. | Tuersunjiang Keyoumu, Ke Guo, Wanbiao Ma, Periodic oscillation for a class of in-host MERS-CoV infection model with CTL immune response, 2022, 19, 1551-0018, 12247, 10.3934/mbe.2022570 | |
3. | Ahmed M. Elaiw, Amani S. Alsulami, Aatef D. Hobiny, Global properties of delayed models for SARS-CoV-2 infection mediated by ACE2 receptor with humoral immunity, 2024, 9, 2473-6988, 1046, 10.3934/math.2024052 | |
4. | Jinlong Lv, Wanbiao Ma, Delay induced stability switch in a mathematical model of CD8 T-cell response to SARS-CoV-2 mediated by receptor ACE2, 2024, 34, 1054-1500, 10.1063/5.0187872 |